Andrew Jenkins

Dr. Andrew Jenkins is an Associate Professor of Pharmaceutical Sciences at the University of Saint Joseph (USJ), School of Pharmacy and Physician Assistant Studies. He holds a Ph.D. and B.Sc. from Imperial College, University of London. Previously, he served as Director of Graduate Studies and Associate Professor in Pharmacology at Emory University's School of Medicine. His research focuses on GABA receptor pharmacology, ion channel dysfunction, and translational therapies for neurological and oncological disorders. Key areas include anesthetic mechanisms, cancer immunotherapy, and genetic epilepsy.

His work integrates electrophysiology, stem cell models, and drug screening to explore novel therapeutic targets. Notable contributions include studies on benzodiazepine derivatives in medulloblastoma and radiation-chemotherapy synergies in melanoma. His research has been published in high-impact journals across neuroscience, pharmacology, and oncology.

• Education: Ph.D., D.I.C. (Imperial College, London), B.Sc., A.R.C.S. (Imperial College, London)
• Key Affiliations: Formerly at Emory University (School of Medicine), Weill Cornell Medical College, and University of Chicago.

Publications highlight his expertise in ion channel pharmacology, drug development, and translational medicine. Ongoing projects focus on GABA receptor modulation in cancer and neurological diseases, leveraging cutting-edge electrophysiology and computational modeling.